Erasca Inc (ERAS) — Who's Buying and Selling (13F, Q2 2026)

ERAS ranks #2433 out of 37696 tracked stocks by institutional interest — one of the most closely watched names in our coverage.

ERAS is a top-conviction position for ARCH Venture Management, LLC — at 11.8% of their entire disclosed 13F portfolio, it's one of their largest single bets, not just a passing allocation.

The largest dollar stake in ERAS belongs to Frazier Life Sciences Management, L.P., but the position matters far more to ARCH Venture Management, LLC, who has 11.8% of their own portfolio riding on it — a reminder that the biggest holder by size and the holder with the biggest bet aren't always the same fund.

Fortitude Family Office, LLC has added to its ERAS position for two straight quarters, increasing it by $6.3K to reach $9.8K today.

ERAS is down 10% today, but institutions show net buying of $655.8M this quarter — a divergence between today's price move and the underlying institutional flow.

ERAS reported a net loss of $124.5M in its latest fiscal year.

• Not yet profitable — net loss of $124.5M in the latest fiscal year
• Net income improved year over year, from -$161.7M to -$124.5M
• Operating cash flow was negative, using $95.5M in cash
• Current ratio of 10.04x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.22x equity — within a conventional range